Gwendolyn A. Watanabe - Aug 1, 2023 Form 4 Insider Report for Compute Health Acquisition Corp. (CPUH)

Role
Director
Signature
/s/ Joshua Fink, as attorney-in-fact
Stock symbol
CPUH
Transactions as of
Aug 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/3/2023, 04:39 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPUH Class A Common Stock Award +21.1K 21.1K Aug 1, 2023 Direct F1, F2
transaction CPUH Class A Common Stock Disposed to Issuer -21.1K -100% 0 Aug 1, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPUH Class B Common Stock Disposed to Issuer -30K -100% 0 Aug 1, 2023 Class A Common Stock 30K Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gwendolyn A. Watanabe is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects transactions in connection with that certain Business Combination Agreement (the "Business Combination Agreement"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) ("Allurion"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) ("Pubco") and the other parties thereto (the "Business Combination").
F2 Reflects the conversion of 30,000 shares of the issuer's Class B common stock, par value $0.0001 ("Class B Common Stock"), held by Ms. Watanabe into 21,120 shares of the issuer's Class A common stock, $0.0001 par value ("Class A Common Stock"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, by and among the issuer, Compute Health Sponsor LLC, Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination.
F3 Pursuant to the terms of the Business Combination Agreement, each share of Class A Common Stock was canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value.
F4 As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading "Description of Securities--Founder Shares," the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date.